Vitro S.A.B. de C.V (VITROA) - Total Liabilities
Based on the latest financial reports, Vitro S.A.B. de C.V (VITROA) has total liabilities worth MX$965.25 Million MXN (≈ $55.55 Million USD) as of December 2023. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Vitro S.A.B. de C.V - Total Liabilities Trend (2000–2023)
This chart illustrates how Vitro S.A.B. de C.V's total liabilities have evolved over time, based on quarterly financial data. See Vitro S.A.B. de C.V short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Vitro S.A.B. de C.V Competitors by Total Liabilities
The table below lists competitors of Vitro S.A.B. de C.V ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Wam Research Ltd
AU:WAX
|
Australia | AU$17.07 Million |
|
Elanor Commercial Property Fund
AU:ECF
|
Australia | AU$213.27 Million |
|
Seshasayee Paper and Boards Limited
NSE:SESHAPAPER
|
India | Rs4.71 Billion |
|
AGV Products Corp
TW:1217
|
Taiwan | NT$7.35 Billion |
|
E KOCREF CR REIT
KO:088260
|
Korea | ₩453.23 Billion |
|
Cristales
SN:CRISTALES
|
Chile | CL$356.92 Billion |
|
Goodbaby International Holdings Limited
F:GBH
|
Germany | €4.34 Billion |
|
ProQR Therapeutics BV
NASDAQ:PRQR
|
USA | $67.28 Million |
Liability Composition Analysis (2000–2023)
This chart breaks down Vitro S.A.B. de C.V's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Vitro S.A.B. de C.V market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.34 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.44 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.59 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Vitro S.A.B. de C.V's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Vitro S.A.B. de C.V (2000–2023)
The table below shows the annual total liabilities of Vitro S.A.B. de C.V from 2000 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | MX$965.25 Million ≈ $55.55 Million |
-28.62% |
| 2022-12-31 | MX$1.35 Billion ≈ $77.83 Million |
+1.00% |
| 2021-12-31 | MX$1.34 Billion ≈ $77.06 Million |
-15.69% |
| 2020-12-31 | MX$1.59 Billion ≈ $91.40 Million |
+16.47% |
| 2019-12-31 | MX$1.36 Billion ≈ $78.47 Million |
+4.68% |
| 2018-12-31 | MX$1.30 Billion ≈ $74.97 Million |
+0.84% |
| 2017-12-31 | MX$1.29 Billion ≈ $74.34 Million |
+29.20% |
| 2016-12-31 | MX$999.84 Million ≈ $57.54 Million |
-86.82% |
| 2015-12-31 | MX$7.59 Billion ≈ $436.69 Million |
-71.88% |
| 2014-12-31 | MX$26.98 Billion ≈ $1.55 Billion |
-0.23% |
| 2013-12-31 | MX$27.05 Billion ≈ $1.56 Billion |
-9.62% |
| 2012-12-31 | MX$29.93 Billion ≈ $1.72 Billion |
-6.95% |
| 2011-12-31 | MX$32.16 Billion ≈ $1.85 Billion |
+6.40% |
| 2010-12-31 | MX$30.23 Billion ≈ $1.74 Billion |
-1.44% |
| 2009-12-31 | MX$30.67 Billion ≈ $1.76 Billion |
-0.56% |
| 2008-12-31 | MX$30.84 Billion ≈ $1.77 Billion |
+35.26% |
| 2007-12-31 | MX$22.80 Billion ≈ $1.31 Billion |
+25.08% |
| 2006-12-31 | MX$18.23 Billion ≈ $1.05 Billion |
-16.17% |
| 2005-12-31 | MX$21.75 Billion ≈ $1.25 Billion |
-5.78% |
| 2004-12-31 | MX$23.08 Billion ≈ $1.33 Billion |
+3.81% |
| 2003-12-31 | MX$22.23 Billion ≈ $1.28 Billion |
+3.80% |
| 2002-12-31 | MX$21.42 Billion ≈ $1.23 Billion |
-4.72% |
| 2001-12-31 | MX$22.48 Billion ≈ $1.29 Billion |
-1.61% |
| 2000-12-31 | MX$22.85 Billion ≈ $1.31 Billion |
-- |
About Vitro S.A.B. de C.V
Vitro, S.A.B. de C.V., through its subsidiaries, produces, processes, distributes, and markets inorganic chemical products worldwide. The company provides sodium carbonate and bicarbonate, calcium chloride, and sodium chloride. It serves automotive, glass, detergent, water treatment, pharmaceutical, food, oil, road deicing, and livestock sectors. Vitro, S.A.B. de C.V. was founded in 1909 and is b… Read more